Jason B. Reddish focuses his practice on the federal 340B drug discount program and the complex legal and compliance issues facing safety net providers, pharmacies, and other 340B program stakeholders.  Mr. Reddish began his career representing pharmaceutical manufacturers before finding his passion helping 340B program covered entities, including disproportionate share hospitals, Federally Qualified Health Centers, Ryan White HIV/AIDS clinics, and other grantees navigate the 340B program.

In addition to providing guidance on 340B program issues, Mr. Reddish helps safety net providers, pharmacies, and other stakeholders by negotiating and reviewing contracts relating to the provision of pharmacy and professional services, including dozens of 340B program contract pharmacy and pharmacy services agreements.  Mr. Reddish is an authority on 340B program contract pharmacies, including transactional, operational, and compliance concerns.

Mr. Reddish is committed to ensuring that safety net providers are able to stretch their limited resources to best serve their vulnerable patient populations.

Published Works

  • Jason B. Reddish, New FDA Rules Permit States to Import Drugs from Canada, American Health Law Association (October 2020)
  • Jason B. Reddish, Co-Author, Legal Brief: State Medicaid Alternative Reimbursement and Purchasing Test for High-Cost Drugs, Center for Evidence-Based Policy, Oregon Health & Science University (2016)
  • Jason B. Reddish, Co-Author, Representing Hospitals and Health Systems Handbook, Chapter 27 (340B Issues), American Health Lawyers Association (2016)
Jason B. Reddish


  • J.D., Tulane Law School, cum laude (2005)
  • B.S., University of Maryland (2001)

Bar/Court Admissions

  • District of Columbia
  • Maryland

Professional Memberships / Affiliations

  • American Bar Association
  • American Health Law Association
  • American Society for Pharmacy Law
  • D.C. Bar, Health Law Section Steering Committee
  • Maryland State Bar Association